<SEC-DOCUMENT>0001193125-15-392055-index.html : 20151201 <SEC-HEADER>0001193125-15-392055.hdr.sgml : 20151201 <ACCEPTANCE-DATETIME>20151201163058 ACCESSION NUMBER: 0001193125-15-392055 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151201 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151201 DATE AS OF CHANGE: 20151201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151262724 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>d89581d8k.htm <DESCRIPTION>FORM 8-K <TEXT> Document 1 - file: d89581d8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>d89581dex41.htm <DESCRIPTION>EX-4.1 <TEXT> Document 2 - file: d89581dex41.htm
</DOCUMENT> </SEC-DOCUMENT>